UBS lowered the firm’s price target on Celanese (CE) to $49 from $66 and keeps a Neutral rating on the shares.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CE:
- Celanese: Resilient Performance and Strategic Moves Justify Buy Rating Despite Challenges
- Celanese Secures New $1.75 Billion Credit Facility
- Celanese CEO to Present Q2 2025 Financial Results
- Celanese reports Q2 adjusted EPS $1.44, consensus $1.40
- Celanese sees Q3 adjusted EPS $1.10-$1.40, consensus $1.73
